SOLENO THERAPEUTICS INC - Common Stock (SLNO)
CUSIP: 834203309
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 51,352,116
- Total 13F shares
- 56,749,470
- Share change
- +2,177,111
- Total reported value
- $4,754,316,405
- Put/Call ratio
- 116%
- Price per share
- $83.78
- Number of holders
- 231
- Value change
- +$213,454,357
- Number of buys
- 155
- Number of sells
- 91
Quarterly Holders Quick Answers
What is CUSIP 834203309?
CUSIP 834203309 identifies SLNO - SOLENO THERAPEUTICS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 834203309:
Top shareholders of SLNO - SOLENO THERAPEUTICS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Abingworth LLP |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
25,774,464
mixed-class rows
|
$657,560,041 | — | 21 Dec 2018 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
10%
|
5,140,899
|
$370,024,378 | — | 31 Mar 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
8.7%
|
4,458,294
|
$318,545,106 | — | 31 Mar 2025 | |
| Vivo Opportunity, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,458,294
|
$314,755,556 | — | 26 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
13D/G
|
Company · Adage Capital Management, L.P. |
6.4%
from 13D/G
|
4,392,696
|
$313,858,129 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
13F
|
T. Rowe Price Associates, Inc. · Company |
6.9%
|
3,461,510
|
$299,939,842 | +$91,911,561 | 30 Jun 2025 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4.9%
|
2,525,000
|
$180,411,250 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
4.3%
|
2,233,473
|
$159,581,640 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
3.7%
|
1,913,326
|
$136,707,143 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
1,866,326
|
$133,348,993 | — | 31 Mar 2025 | |
| Nantahala Capital Management, LLC |
13F
13D/G
|
Company |
2%
from 13D/G
|
1,757,023
|
$125,539,293 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.1%
|
1,576,044
|
$112,608,344 | — | 31 Mar 2025 | |
| PERCEPTIVE ADVISORS LLC |
3/4/5
13F
|
10%+ Owner · Company |
2.9%
from 13F
|
3,324,542
mixed-class rows
|
$112,175,587 | — | 26 Sep 2023 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
2.4%
|
1,211,245
|
$86,543,455 | — | 31 Mar 2025 | |
| Holocene Advisors, LP |
13F
|
Company |
2.3%
|
1,196,990
|
$85,524,936 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
1,169,199
|
$83,539,269 | — | 31 Mar 2025 | |
| Commodore Capital LP |
13F
|
Company |
2.2%
|
1,150,000
|
$82,167,500 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.8%
|
915,995
|
$65,447,808 | — | 31 Mar 2025 | |
| Carlyle Group Inc. |
13F
3/4/5
|
Company · 10%+ Owner |
1.7%
|
860,980
|
$61,448,143 | — | 31 Mar 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.6%
|
837,836
|
$59,863,382 | — | 31 Mar 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
1.4%
|
727,337
|
$51,968,229 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.4%
|
693,644
|
$49,560,863 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.3%
|
679,291
|
$48,535,342 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
633,110
|
$45,235,709 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
615,736
|
$44,004,245 | — | 31 Mar 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
1.2%
|
595,206
|
$42,527,469 | — | 31 Mar 2025 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
1.1%
|
564,481
|
$40,332,167 | — | 31 Mar 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
1%
|
529,209
|
$37,811,983 | — | 31 Mar 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.97%
|
500,000
|
$35,725,000 | — | 31 Mar 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.97%
|
499,159
|
$35,664,911 | — | 31 Mar 2025 | |
| Artia Global Partners LP |
13F
|
Company |
0.97%
|
498,473
|
$35,615,896 | — | 31 Mar 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.94%
|
484,471
|
$34,615,453 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.91%
|
467,193
|
$33,380,940 | — | 31 Mar 2025 | |
| Capital World Investors |
13F
|
Company |
0.91%
|
464,833
|
$33,212,318 | — | 31 Mar 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.85%
|
434,514
|
$31,046,025 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.84%
|
430,059
|
$30,727,716 | — | 31 Mar 2025 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.72%
|
371,697
|
$26,557,751 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.68%
|
349,664
|
$24,983,493 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.59%
|
302,664
|
$21,625,347 | — | 31 Mar 2025 | |
| Caption Management, LLC |
13F
|
Company |
0.57%
|
295,000
|
$21,077,750 | — | 31 Mar 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
0.54%
|
275,000
|
$19,648,750 | — | 31 Mar 2025 | |
| SOROS FUND MANAGEMENT LLC |
13F
|
Company |
0.53%
|
270,663
|
$19,338,871 | — | 31 Mar 2025 | |
| Logos Global Management LP |
13F
|
Company |
0.49%
|
250,000
|
$17,862,500 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.48%
|
247,737
|
$17,700,809 | — | 31 Mar 2025 | |
| Tri Locum Partners LP |
13F
|
Company |
0.46%
|
234,920
|
$16,785,034 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.45%
|
232,336
|
$16,600,408 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.43%
|
223,287
|
$15,953,856 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.42%
|
213,984
|
$15,289,157 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.41%
|
212,359
|
$15,173,077 | — | 31 Mar 2025 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.4%
|
206,600
|
$14,761,570 | — | 31 Mar 2025 |
Institutional Holders of SOLENO THERAPEUTICS INC - Common Stock (SLNO) as of Q2 2025
As of 30 Jun 2025,
SOLENO THERAPEUTICS INC - Common Stock (SLNO) was held by
231 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,749,470 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, Vivo Capital, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, CITADEL ADVISORS LLC, and WESTFIELD CAPITAL MANAGEMENT CO LP.
This page lists
232
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
215
Q2 2025 holders
231
Holder diff
16
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.